Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction

Otolaryngology - Head and Neck Surgery (United States)

Volumn 159, Issue 1, 2018, Pages 59-67

  Veve, Michael P ^a,b   Greene, Joshua B ^b   Williams, Amy M ^b   Davis, Susan L ^a,b   Lu, Nina ^c   Shnayder, Yelizaveta ^c   Li, David X ^d   Noureldine, Salem I ^d   Richmon, Jeremy D ^d   Lin, Lawrence O ^e   Hanasono, Matthew M ^e   Pipkorn, Patrik ^f   Jackson, Ryan S ^f   Hornig, Joshua D ^g   Light, Tyler ^h   Wax, Mark K ^h   Yiu, Yin ⁱ   Bekeny, James ⁱ   Old, Matthew ⁱ   Hernandez, David ^j   Patel, Urjeet A ^j   Ghanem, Tamer A ^a,b   more..

^a WAYNE STATE UNIVERSITY   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h The Ohio State University Wexner Medical Center ^*

ⁱ THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

antibiotic postoperative prophylaxis; antimicrobial stewardship; head and neck cancer microvascular reconstruction; surgical site infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ABSCESS; ACINETOBACTER BAUMANNII; ADULT; AGED; ANAEROBE; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL STEWARDSHIP; ARTICLE; CANCER SURGERY; CANDIDA; CASE CONTROL STUDY; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; FREE TISSUE GRAFT; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROVASCULATURE; MIDDLE AGED; MIXED INFECTION; MONOTHERAPY; PREVALENCE; PROTEUS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SURGICAL INFECTION; SURGICAL WOUND; TREATMENT OUTCOME; TUMOR ABLATION; CLINICAL TRIAL; HEAD AND NECK TUMOR; MULTICENTER STUDY; VASCULAR SURGERY;

AGED; ANTIBIOTIC PROPHYLAXIS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; RISK FACTORS; SURGICAL WOUND INFECTION; VASCULAR SURGICAL PROCEDURES;

EID: 85045322128     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599818756299     Document Type: Article

References (49)

1. Urken ML, Weinberg H, Buchbinder D. Microvascular free flaps in head and neck reconstruction: report of 200 cases and review of complications. Arch Otolaryngol Head Neck Surg. 1994;120:633-640
2. Centers for Disease Control and Prevention. Surgical site infection (SSI) event definitions. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Published January 2016. Accessed October 2015
3. Cunha TF, Soares Melancia TA, Zagalo Fernandes Ribeiro CM. Risk factors for surgical site infection in cervico-facial oncological surgery. J Craniomaxillofac Surg. 2012;40:443-448
4. Wagner JL, Kenny RM, Vazquez JA. Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head Neck. 2016;38:1449-1454
5. Hanasono MM., Reconstructive surgery for head and neck cancer patients. Adv Med. 2014;2014:795483
6. Yarlagadda BB, Deschler DG, Rich DL. Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Head Neck. 2016;38(suppl 1):E392-E398
7. Karakida K, Aoki T, Ota Y. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother. 2010;16:334-339
8. Lotfi CJ, de Cassia Calvalcanti R, Costa e, Silva AM. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2008;138:74-80
9. Barry B, Lucet JC, Kosmann MJ. Risk factors for surgical wound infections in patients undergoing head and neck oncologic surgery. Acta Otolaryngol. 1999;53:241-244
10. Penel N, Lefebvre D, Fournier C. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck. 2001;23:447-455
11. Dor P, Klastersky J., Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: a double-blind study. Laryngoscope. 1973;83:1992-1998
12. Ketcham AS, Bloch JH, Crawford DT. The role of prophylactic antibiotic therapy in control of staphylococcal infections following cancer surgery. Surg Gynecol Obstet. 1962;114:345-352
13. Becker GD, Parell GJ., Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol. 1979;88:183-186
14. Mandell-Brown M, Johnson JT, Wagner RL., Cost-effectiveness of prophylactic antibiotics in head and neck surgery. Otolaryngol Head Neck Surg. 1984;92:520-523
15. Bratzler DW, Dellinger EP, Olsen KM. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 2013;70:195-283
16. Johnson JT, Yu VL, Myers EN. Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol. 1984;110:224-227
17. Brook I, Hirokawa R., Microbiology of wound infection after head and neck cancer surgery. Ann Otol Rhinol Laryngol. 1989;98:323-325
18. Man LX, Beswick DM, Johnson JT., Antibiotic prophylaxis in uncontaminated neck dissection. Laryngoscope. 2011;121:1473-1477
19. Durand ML, Yarlagadda BB, Rich DL. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope. 2015;125:1084-1089
20. Yang CH, Chew KY, Solomkin JS. Surgical site infections among high-risk patients in clean-contaminated head and neck reconstructive surgery: concordance with preoperative oral flora. Ann Plast Surg. 2013;71(suppl 1):S55-S60
21. Skitarelić N, Morović M, Manestar D., Antibiotic prophylaxis in clean-contaminated head and neck oncological surgery. J Craniomaxillofac Surg. 2007;35:15-20
22. Simons JP, Johnson JT, Yu VL. The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope. 2001;111:329-335
23. Chambers RM, Davis SL., Expanding the reach of antimicrobial stewardship. Pharmacotherapy. 2013;33:118
24. Barlam TF, Cosgrove SE, Abbo LM. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51-e77
25. Russell MD, Goldberg AN., What is the evidence for use of prophylactic antibiotics in clean-contaminated head and neck surgery? Laryngoscope. 2012;122:945-946
26. Brown KA, Fisman DN, Moineddin R. The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study. PLoS One. 2014;9(8):e105454
27. American College of Surgeons National Surgical Quality Improvement Program. Data variables and definitions. https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_userguide_2014.ashx. Published October 2015. Accessed October 2015
28. Weber RS, Raad I, Frankenthaler R. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery: the need for gram-negative coverage. Arch Otolaryngol Head Neck Surg. 1992;118:1159-1163
29. Callender DL., Antibiotic prophylaxis in head and neck oncologic surgery: the role of gram-negative coverage. Int J Antimicrob Agents. 1999;12(suppl 1):s21-s27
30. Mitchell RM, Mendez E, Schmitt NC. Antibiotic prophylaxis in patients undergoing head and neck free flap reconstruction. JAMA Otolaryngol Head Neck Surg. 2015;141:1096-1103
31. Johnson JT, Yu VL., Antibiotic use during major head and neck surgery. Ann Surg. 1988;207:108-111
32. Johnson JT, Yu VL, Myers EN. An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis. 1987;155:331-333
33. Johnson JT, Yu VL., Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck. 1989;11:27-29
34. Pool C, Kass J, Spivack J. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg. 2016;154:272-278
35. Murphy J, Isaiah A, Dyalram D, Lubek JE., Surgical site infections in patients receiving osteomyocutaneous free flaps to the head and neck: does choice of antibiotic prophylaxis matter? J Oral Maxillofac Surg. 2017;75(10):2223-2229
36. Langerman A, Thisted R, Hohmann S. Antibiotic and duration of perioperative prophylaxis predicts surgical site infection in head and neck surgery. Otolaryngol Head Neck Surg. 2016;154:1054-1063
37. Johnson JT, Schuller DE, Silver F. Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs five-day therapy. Otolaryngol Head Neck Surg. 1986;95:554-557
38. Piccart M, Dor P, Klastersky J., Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis Suppl. 1983;39:92-96
39. Bhathena HM, Kavarana NM., Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime. Acta Chir Plast. 1998;40:36-40
40. Carroll WR, Rosenstiel D, Fix JR. Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129:771-774
41. Khariwala SS, Le B, Pierce BH. Antibiotic use after free tissue reconstruction of head and neck defects: short course vs long course. Surg Infect (Larchmt). 2016;17:100-105
42. Sephr A, Gutierrez Santos B, Chou C. Antibiotics in head and neck surgery in the setting of malnutrition, tracheotomy, and diabetes. Laryngoscope. 2009;119:549-553
43. World Health Organization. Global guidelines for the prevention of surgical site infection. http://who.int/gpsc/global-guidelines-web.pdf?ua=1. Published November 2016. Accessed November 2016
44. Berríos-Torres SI, Umscheid CA, Bratzler DW. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784-791
45. Cohen LE, Finnerty BM, Reiffel Golas A. Perioperative antibiotics in the setting of oropharyngeal reconstruction: less is more. Ann Plast Surg. 2016;76:663-667
46. Reiffel AJ, Kamdar MR, Kadouch DJ. Perioperative antibiotics in the setting of microvascular free tissue transfer: current practices. J Reconstr Microsurg. 2010;26:401-407
47. Bartella AK, Kamal M, Teichmann J. Prospective comparison of perioperative antibiotic management protocols in oncological head and neck surgery. J Craniomaxillofac Surg. 2017;45:1078-1082
48. Veve MP, Davis SL, Williams AM, McKinnon JE, Ghanem TA., Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol. 2017;74:181-187
49. Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES., The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis. 2017:cix794. doi:10.1093/cid/cix794